Home » Topics » BioWorld

BioWorld
RSS

NIH FUNDS LIPID-BASED AIDS DRUG

Oct. 9, 1991

CANCER TREATMENT COMBINES THERAPIES

Oct. 9, 1991

ECOGEN SIGNS DISTRIBUTION DEAL

Oct. 8, 1991

GLYCOMED TO FILE 2 MILLION-SHARE OFFERING

Oct. 8, 1991

HIGH COURT REJECTS GI'S EPO PATENT APPEAL

Oct. 8, 1991

Biogen R&D Agreement for Hirulog

Oct. 8, 1991

ONCOGENE COMPLETES ACQUISITION

Oct. 8, 1991

REPLIGEN GETS PATENT RIGHTS FOR ANTIBODIES

Oct. 8, 1991

MID-ATLANTIC VENTURE FAIR

Oct. 7, 1991

APPOINTMENTS AND ADVANCEMENTS

Oct. 7, 1991

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...